Biopharmaceutical industry impact on added value U.S. 2015

This statistic shows the impact of the biopharmaceutical industry on added value in the United States in 2015. In that year, the direct effect of the U.S. biopharmaceutical industry on value added was some 270 billion US dollars.

Impact of the U.S. biopharmaceutical industry on added value in 2015

ImpactValue added in billion U.S. dollars
Direct effect270
Indirect impacts211.6
Induced impacts187.8
Total impact669.4
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

October 2017

Region

United States

Survey time period

2015

Supplementary notes

Value added: the difference between an industry's or an establishments total output and the coast of its intermediate inputs.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.